Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DOCUSIGN, INC. Director's Dealing 2020

Jul 7, 2020

30367_dirs_2020-07-07_d986ccb6-db10-4f80-83d2-18d73641358e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DOCUSIGN, INC. (DOCU)
CIK: 0001261333
Period of Report: 2020-07-02

Reporting Person: Salem Enrique T (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-07-02 Common Stock S 1000 $180.257 Disposed 2035745 Indirect
2020-07-02 Common Stock S 2920 $182.014 Disposed 2032825 Indirect
2020-07-02 Common Stock S 2100 $182.6743 Disposed 2030725 Indirect
2020-07-02 Common Stock S 3200 $183.8808 Disposed 2027525 Indirect
2020-07-02 Common Stock S 4805 $185.1524 Disposed 2022720 Indirect
2020-07-02 Common Stock S 6003 $185.9395 Disposed 2016717 Indirect
2020-07-02 Common Stock S 4810 $187.1032 Disposed 2011907 Indirect
2020-07-02 Common Stock S 5700 $187.9972 Disposed 2006207 Indirect
2020-07-02 Common Stock S 4784 $189.1723 Disposed 2001423 Indirect
2020-07-02 Common Stock S 4647 $189.7831 Disposed 1996776 Indirect
2020-07-02 Common Stock S 3735 $191.0131 Disposed 1993041 Indirect
2020-07-02 Common Stock S 2000 $192.2865 Disposed 1991041 Indirect
2020-07-02 Common Stock S 1500 $193.4653 Disposed 1989541 Indirect
2020-07-02 Common Stock S 1941 $194.3347 Disposed 1987600 Indirect
2020-07-02 Common Stock S 100 $194.98 Disposed 1987500 Indirect
2020-07-06 Common Stock S 15000 $197.6921 Disposed 152990 Direct

Footnotes

F1: Represents shares of Common Stock held directly by BCIP Venture Associates ("BCIP Venture"), BCIP Venture Associates-B ("BCIP Venture-B"), BCIP Venture Associates II, L.P. ("BCIP Venture II"), BCIP Venture Associates II-B, L.P. ("BCIP Venture II-B"), Bain Capital Venture Fund 2014, L.P. ("Venture Fund 2014"), Bain Capital Venture Partners 2014, L.P. ("Venture Partners 2014"), Bain Capital Venture Coinvestment Fund, L.P. ("Coinvestment Fund") and Bain Capital Venture Coinvestment Partners, L.P. ("Coinvestment Partners" and, collectively, the "Bain Venture Entities").

F2: Bain Capital Venture Investors, LLC ("BCVI") is (i) the general partner of Venture Partners 2014 and Coinvestment Partners, (ii) the ultimate general partner of Venture Fund 2014 and Coinvestment Fund and (iii) governs the investment strategy and decision making process with respect to investments held by each of BCIP Venture, BCIP Venture-B, BCIP Venture II and BCIP Venture II-B. Mr. Salem is a member of the Executive Committee and a Managing Director of BCVI. By virtue of the relationships described in this footnote, Mr. Salem may be deemed to share voting and dispositive power with respect to all of the shares of Common Stock held by the Bain Venture Entities. Mr. Salem disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $179.86 to $180.86, inclusive. The reporting person undertakes to provide to DocuSign, Inc., any security holder of DocuSign, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (17) to this Form 4.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $181.40 to $182.38, inclusive.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.43 to $183.29, inclusive.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $183.44 to $184.35, inclusive.

F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $184.50 to $185.49, inclusive.

F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.51 to $186.49, inclusive.

F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.53 to $187.52, inclusive.

F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $187.57 to $188.50, inclusive.

F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.59 to $189.59, inclusive.

F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.60 to $190.46, inclusive.

F13: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.62 to $191.48, inclusive.

F14: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.82 to $192.82, inclusive.

F15: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.88 to $193.83, inclusive.

F16: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.89 to $194.87, inclusive.

F17: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.50 to $197.815, inclusive.

F18: Includes 89,811 shares previously reported as indirectly owned by Mr. Salem through NPI Capital, LLC.